544350 Stock Overview

Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. More details

544350 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	1/6
Financial Health	3/6
Dividends	0/6

Rewards

Earnings are forecast to grow 31.22% per year

Earnings have grown 43.8% per year over the past 5 years

Risk Analysis

Large one-off items impacting financial results

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Dr. Agarwal's Health Care Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Dr. Agarwal's Health Care
Historical stock prices
Current Share Price	₹397.15
52 Week High	₹463.85
52 Week Low	₹330.45
Beta	0
1 Month Change	-1.35%
3 Month Change	-6.48%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-1.10%

Recent updates

Shareholder Returns

	544350	IN Healthcare	IN Market
7D	11.7%	3.7%	6.3%
1Y	n/a	25.8%	4.0%

Return vs Industry: Insufficient data to determine how 544350 performed against the Indian Healthcare industry.

Return vs Market: Insufficient data to determine how 544350 performed against the Indian Market.

Price Volatility

Is 544350's price volatile compared to industry and market?
544350 volatility
544350 Average Weekly Movement	4.7%
Healthcare Industry Average Movement	6.1%
Market Average Movement	7.1%
10% most volatile stocks in IN Market	9.8%
10% least volatile stocks in IN Market	4.7%

Stable Share Price: 544350 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine 544350's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2010	4,858	Adil Agarwal	www.dragarwals.co.in

Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services.

Dr. Agarwal's Health Care Limited Fundamentals Summary

How do Dr. Agarwal's Health Care's earnings and revenue compare to its market cap?
544350 fundamental statistics
Market cap	₹125.70b
Earnings (TTM)	₹896.41m
Revenue (TTM)	₹16.00b

140.2x

P/E Ratio

7.9x

P/S Ratio

Is 544350 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
544350 income statement (TTM)
Revenue	₹16.00b
Cost of Revenue	₹9.19b
Gross Profit	₹6.81b
Other Expenses	₹5.91b
Earnings	₹896.41m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	2.84
Gross Margin	42.57%
Net Profit Margin	5.60%
Debt/Equity Ratio	66.4%

How did 544350 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/18 07:28
End of Day Share Price	2025/05/16 00:00
Earnings	2024/12/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dr. Agarwal's Health Care Limited is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Alok Dalal	Jefferies LLC
Alankar Garude	Kotak Securities (Institutional Equities)
Binay Singh	Morgan Stanley

Dr. Agarwal's Health Care BSE:544350 Stock Report